Lee's Pharmaceutical Holdings Limited

SEHK:950 Voorraadrapport

Marktkapitalisatie: HK$736.0m

Lee's Pharmaceutical Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Lee's Pharmaceutical Holdings has a total shareholder equity of HK$1.6B and total debt of HK$231.5M, which brings its debt-to-equity ratio to 14.2%. Its total assets and total liabilities are HK$2.5B and HK$921.4M respectively. Lee's Pharmaceutical Holdings's EBIT is HK$70.7M making its interest coverage ratio 6.5. It has cash and short-term investments of HK$195.0M.

Belangrijke informatie

14.2%

Verhouding schuld/eigen vermogen

HK$231.47m

Schuld

Rente dekkingsratio6.5x
ContantHK$194.99m
AandelenHK$1.63b
Totaal verplichtingenHK$921.43m
Totaal activaHK$2.55b

Recente financiële gezondheidsupdates

Recent updates

Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem

Sep 04
Lee's Pharmaceutical Holdings' (HKG:950) Earnings Are Weaker Than They Seem

There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price

Aug 07
There's Reason For Concern Over Lee's Pharmaceutical Holdings Limited's (HKG:950) Price

Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

May 21
Lee's Pharmaceutical Holdings (HKG:950) Has Affirmed Its Dividend Of HK$0.01

Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Dec 20
Optimistic Investors Push Lee's Pharmaceutical Holdings Limited (HKG:950) Shares Up 28% But Growth Is Lacking

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

May 21
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Apr 02
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Aug 29
Lee's Pharmaceutical Holdings' (HKG:950) Dividend Is Being Reduced To HK$0.01

Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Apr 05
Does Lee's Pharmaceutical Holdings (HKG:950) Have A Healthy Balance Sheet?

Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Mar 17
Can Mixed Fundamentals Have A Negative Impact on Lee's Pharmaceutical Holdings Limited (HKG:950) Current Share Price Momentum?

Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

Feb 22
Should You Buy Lee's Pharmaceutical Holdings Limited (HKG:950) For Its 0.9% Dividend?

What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 29
What Type Of Returns Would Lee's Pharmaceutical Holdings'(HKG:950) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Jan 12
What Type Of Shareholders Own The Most Number of Lee's Pharmaceutical Holdings Limited (HKG:950) Shares?

Analyse van de financiële positie

Kortlopende schulden: 950's short term assets (HK$696.8M) exceed its short term liabilities (HK$632.6M).

Langlopende schulden: 950's short term assets (HK$696.8M) exceed its long term liabilities (HK$288.8M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 950's net debt to equity ratio (2.2%) is considered satisfactory.

Schuld verminderen: 950's debt to equity ratio has increased from 5.4% to 14.2% over the past 5 years.

Schuldendekking: 950's debt is well covered by operating cash flow (56.2%).

Rentedekking: 950's interest payments on its debt are well covered by EBIT (6.5x coverage).


Balans


Ontdek gezonde bedrijven